Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 43 | 2024 | 3250 | 4.260 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 12 | 2024 | 256 | 2.140 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 8 | 2024 | 558 | 1.860 |
Why?
|
Neuromyelitis Optica | 10 | 2019 | 266 | 1.570 |
Why?
|
Spinal Cord | 13 | 2020 | 1811 | 1.280 |
Why?
|
Diffusion Magnetic Resonance Imaging | 17 | 2024 | 2815 | 1.190 |
Why?
|
Atrophy | 8 | 2024 | 1646 | 1.170 |
Why?
|
Axons | 10 | 2021 | 1677 | 0.900 |
Why?
|
Corpus Callosum | 3 | 2022 | 753 | 0.700 |
Why?
|
Cognitive Reserve | 1 | 2020 | 92 | 0.670 |
Why?
|
Thalamus | 2 | 2024 | 1047 | 0.610 |
Why?
|
Magnetic Resonance Imaging | 32 | 2024 | 36743 | 0.590 |
Why?
|
Brain Mapping | 3 | 2018 | 6685 | 0.560 |
Why?
|
Cerebral Cortex | 8 | 2024 | 5812 | 0.550 |
Why?
|
Brain | 16 | 2023 | 27360 | 0.530 |
Why?
|
Neural Pathways | 2 | 2018 | 3117 | 0.520 |
Why?
|
Rest | 1 | 2020 | 948 | 0.490 |
Why?
|
Phosphodiesterase Inhibitors | 4 | 2021 | 213 | 0.480 |
Why?
|
Disability Evaluation | 6 | 2022 | 1835 | 0.470 |
Why?
|
Autoantibodies | 4 | 2024 | 2121 | 0.430 |
Why?
|
Nerve Net | 3 | 2024 | 2352 | 0.420 |
Why?
|
Diffusion Tensor Imaging | 8 | 2020 | 2420 | 0.420 |
Why?
|
Pyridines | 7 | 2024 | 2894 | 0.400 |
Why?
|
Leukoencephalitis, Acute Hemorrhagic | 1 | 2011 | 19 | 0.380 |
Why?
|
Retrograde Degeneration | 1 | 2011 | 8 | 0.370 |
Why?
|
Postpartum Period | 1 | 2017 | 1198 | 0.350 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 2010 | 110 | 0.350 |
Why?
|
Nerve Fibers, Myelinated | 3 | 2012 | 952 | 0.320 |
Why?
|
Receptors, GABA | 2 | 2024 | 312 | 0.320 |
Why?
|
Adult | 49 | 2024 | 223646 | 0.300 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2017 | 3390 | 0.290 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2022 | 9015 | 0.260 |
Why?
|
Immunologic Factors | 2 | 2017 | 1596 | 0.250 |
Why?
|
Middle Aged | 40 | 2024 | 223492 | 0.240 |
Why?
|
Myelin Sheath | 5 | 2023 | 652 | 0.230 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2973 | 0.220 |
Why?
|
Male | 43 | 2024 | 364719 | 0.210 |
Why?
|
Humans | 69 | 2024 | 768166 | 0.210 |
Why?
|
Female | 46 | 2024 | 397192 | 0.200 |
Why?
|
Meninges | 1 | 2024 | 197 | 0.200 |
Why?
|
Antibody Formation | 1 | 2007 | 1393 | 0.200 |
Why?
|
Internationality | 2 | 2019 | 1008 | 0.190 |
Why?
|
Positron-Emission Tomography | 7 | 2024 | 6669 | 0.180 |
Why?
|
Cerebellum | 2 | 2019 | 1522 | 0.180 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4568 | 0.160 |
Why?
|
Young Adult | 16 | 2024 | 60066 | 0.150 |
Why?
|
Pattern Recognition, Automated | 2 | 2014 | 993 | 0.140 |
Why?
|
Aquaporin 4 | 2 | 2009 | 161 | 0.140 |
Why?
|
Nerve Fibers | 1 | 2020 | 709 | 0.130 |
Why?
|
Aging | 3 | 2024 | 8744 | 0.130 |
Why?
|
Retina | 3 | 2020 | 2662 | 0.130 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 667 | 0.130 |
Why?
|
Pyrimidines | 2 | 2019 | 3048 | 0.130 |
Why?
|
Cerebral Veins | 1 | 2016 | 157 | 0.120 |
Why?
|
Bayes Theorem | 1 | 2023 | 2359 | 0.120 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8054 | 0.120 |
Why?
|
Microglia | 2 | 2023 | 1376 | 0.110 |
Why?
|
Reproducibility of Results | 6 | 2021 | 20227 | 0.110 |
Why?
|
Inflammation | 4 | 2019 | 10873 | 0.110 |
Why?
|
B-Lymphocytes | 1 | 2007 | 4793 | 0.110 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26379 | 0.110 |
Why?
|
Optic Neuritis | 2 | 2020 | 175 | 0.110 |
Why?
|
Models, Neurological | 2 | 2019 | 1776 | 0.110 |
Why?
|
Nerve Regeneration | 1 | 2019 | 797 | 0.110 |
Why?
|
Chemokine CXCL13 | 1 | 2013 | 62 | 0.100 |
Why?
|
Image Enhancement | 2 | 2014 | 2880 | 0.100 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9263 | 0.100 |
Why?
|
Diplopia | 1 | 2013 | 217 | 0.100 |
Why?
|
Disease Progression | 7 | 2020 | 13671 | 0.100 |
Why?
|
Pain, Intractable | 1 | 2012 | 132 | 0.100 |
Why?
|
Vertigo | 1 | 2013 | 205 | 0.100 |
Why?
|
Spinal Cord Diseases | 1 | 2013 | 291 | 0.090 |
Why?
|
Parkinson Disease | 1 | 2024 | 2893 | 0.090 |
Why?
|
Sensitivity and Specificity | 4 | 2014 | 14729 | 0.090 |
Why?
|
Myelin Proteins | 1 | 2010 | 212 | 0.080 |
Why?
|
Methylprednisolone | 1 | 2011 | 386 | 0.080 |
Why?
|
Medication Adherence | 1 | 2021 | 2187 | 0.080 |
Why?
|
Paraparesis | 1 | 2009 | 15 | 0.080 |
Why?
|
Tomography, Optical Coherence | 3 | 2020 | 2957 | 0.080 |
Why?
|
Mothers | 1 | 2020 | 2209 | 0.080 |
Why?
|
Wallerian Degeneration | 1 | 2009 | 68 | 0.080 |
Why?
|
Optic Nerve | 2 | 2009 | 571 | 0.080 |
Why?
|
Adolescent | 7 | 2024 | 89169 | 0.080 |
Why?
|
Electrodiagnosis | 1 | 2009 | 149 | 0.080 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2862 | 0.080 |
Why?
|
Muscle Weakness | 1 | 2011 | 412 | 0.070 |
Why?
|
Headache | 2 | 2018 | 1263 | 0.070 |
Why?
|
Selection Bias | 1 | 2009 | 360 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2014 | 2357 | 0.070 |
Why?
|
Interferon-beta | 1 | 2009 | 349 | 0.070 |
Why?
|
Nerve Degeneration | 1 | 2012 | 749 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 3814 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2012 | 15454 | 0.070 |
Why?
|
Consensus | 1 | 2016 | 3212 | 0.070 |
Why?
|
Evoked Potentials, Visual | 1 | 2009 | 418 | 0.070 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 2230 | 0.070 |
Why?
|
Phenotype | 1 | 2024 | 16726 | 0.070 |
Why?
|
Anthropometry | 2 | 2021 | 1346 | 0.060 |
Why?
|
Aged | 12 | 2024 | 171504 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9613 | 0.060 |
Why?
|
Recurrence | 1 | 2017 | 8509 | 0.060 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2024 | 40 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3968 | 0.060 |
Why?
|
Computer Simulation | 1 | 2018 | 6283 | 0.060 |
Why?
|
Brain Diseases | 1 | 2013 | 1554 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2007 | 540 | 0.060 |
Why?
|
Complement System Proteins | 1 | 2007 | 738 | 0.060 |
Why?
|
Immunoglobulins | 1 | 2007 | 855 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3463 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2017 | 3980 | 0.050 |
Why?
|
Prospective Studies | 4 | 2020 | 54926 | 0.050 |
Why?
|
Secondary Prevention | 1 | 2009 | 1474 | 0.050 |
Why?
|
Chemokines | 1 | 2007 | 963 | 0.050 |
Why?
|
Acetamides | 1 | 2024 | 259 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 13014 | 0.050 |
Why?
|
Visual Pathways | 2 | 2020 | 557 | 0.050 |
Why?
|
Environment | 1 | 2007 | 1121 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2021 | 171 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2017 | 4887 | 0.040 |
Why?
|
Electronics | 1 | 2021 | 317 | 0.040 |
Why?
|
Plasmapheresis | 1 | 2020 | 206 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2011 | 2655 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2709 | 0.040 |
Why?
|
Pregnancy | 2 | 2020 | 30256 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7454 | 0.040 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 336 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2012 | 15948 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2007 | 1172 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4354 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59629 | 0.030 |
Why?
|
Longevity | 1 | 2024 | 1077 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2013 | 22291 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4206 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14783 | 0.030 |
Why?
|
Cohort Studies | 4 | 2020 | 41754 | 0.030 |
Why?
|
Anisotropy | 1 | 2017 | 1292 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6314 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2018 | 12465 | 0.030 |
Why?
|
Research Design | 2 | 2021 | 6211 | 0.030 |
Why?
|
Algorithms | 3 | 2019 | 14164 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7140 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3216 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2017 | 1489 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1206 | 0.020 |
Why?
|
Child | 3 | 2024 | 80917 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 3780 | 0.020 |
Why?
|
Neural Conduction | 1 | 2009 | 443 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2012 | 979 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9384 | 0.020 |
Why?
|
Quality Improvement | 1 | 2021 | 3857 | 0.020 |
Why?
|
Retinal Ganglion Cells | 1 | 2009 | 811 | 0.010 |
Why?
|
Quality of Life | 2 | 2016 | 13490 | 0.010 |
Why?
|
United States | 2 | 2021 | 73039 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3583 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10840 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2024 | 81762 | 0.010 |
Why?
|
Depression | 1 | 2018 | 8230 | 0.010 |
Why?
|
Animals | 2 | 2024 | 169246 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36535 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 65371 | 0.010 |
Why?
|
Prognosis | 1 | 2009 | 30010 | 0.000 |
Why?
|
Concepts
(161)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_